Dan Emil Lind (Dan E Gustafsson, Dan E Lind)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Topics

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Oxidative Stress

Magnetic Resonance

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Science signaling

The EMBO journal

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Marcus Borenäs, Ganesh Umapathy, Dan Emil Lind, Wei-Yun Lai, Jikui Guan, Joel Johansson, Eva Jennische, Alexander Schmidt, Yeshwant Kurhe, Jonatan L Gabre, Agata Aniszewska, Anneli Strömberg, Mats Bemark, Michael N Hall, Jimmy Van den Eynden, Bengt Hallberg, Ruth H Palmer
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition. Proceedings of the National Academy of Sciences of the United States of America 121 (1) (2023)
Marcus Borenäs, Ganesh Umapathy, Dan Emil Lind, Wei-Yun Lai, Jikui Guan, Joel Johansson, Eva Jennische, Alexander Schmidt, Yeshwant Kurhe, Jonatan L Gabre, Agata Aniszewska, Anneli Strömberg, Mats Bemark, Michael N Hall, Jimmy Van den Eynden, Bengt Hallberg, Ruth H Palmer
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition. Proceedings of the National Academy of Sciences of the United States of America 121 (1) (2023)
Marcus Borenäs, Ganesh Umapathy, Dan Emil Lind, Wei-Yun Lai, Jikui Guan, Joel Johansson, Eva Jennische, Alexander Schmidt, Yeshwant Kurhe, Jonatan L Gabre, Agata Aniszewska, Anneli Strömberg, Mats Bemark, Michael N Hall, Jimmy Van den Eynden, Bengt Hallberg, Ruth H Palmer
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition. Proceedings of the National Academy of Sciences of the United States of America 121 (1) (2023)
Marcus Borenäs, Ganesh Umapathy, Dan Emil Lind, Wei-Yun Lai, Jikui Guan, Joel Johansson, Eva Jennische, Alexander Schmidt, Yeshwant Kurhe, Jonatan L Gabre, Agata Aniszewska, Anneli Strömberg, Mats Bemark, Michael N Hall, Jimmy Van den Eynden, Bengt Hallberg, Ruth H Palmer
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition. Proceedings of the National Academy of Sciences of the United States of America 121 (1) (2023)
Joanna Szydzik, Dan Emil Lind, Badrul Arefin, Yeshwant Kurhe, Ganesh Umapathy, Joachim Tetteh Siaw, Arne Claeys, Jonatan L Gabre, Jimmy Van den Eynden, Bengt Hallberg, Ruth H Palmer
ATR inhibition enables complete tumour regression in ALK-driven NB mouse models. Nature communications 12 (1) (2021)
Marcus Borenäs, Ganesh Umapathy, Wei-Yun Lai, Dan Emil Lind, Barbara Witek, Jikui Guan, Patricia Mendoza-García, Tafheem Masudi, Arne Claeys, Tzu-Po Chuang, Abeer El Wakil, Badrul Arefin, Susanne Fransson, Jan Koster, Mathias Johansson, Jennie Gaarder, Jimmy Van den Eynden, Bengt Hallberg, Ruth H Palmer
ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK mutation. The EMBO journal 40 (3) (2021)
Diana Cervantes-Madrid, Joanna Szydzik, Dan Emil Lind, Marcus Borenäs, Mats Bemark, Jean Cui, Ruth Helen Palmer, Bengt Hallberg
Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells. Scientific reports 9 (1) (2019)
Ganesh Umapathy, Jikui Guan, Dan Emil Lind, Niloufar Javanmardi, Diana Cervantes-Madrid, Anna Djos, Tommy Martinsson, Ruth H Palmer, Bengt Hallberg
MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)-addicted neuroblastomas. Science signaling 10 (507) (2017)